RBC Antibody ID Prenatal - Reflex to Titer
Ordering Recommendation
Use to identify unexpected red blood cell (RBC) antibodies in a patient's serum and, when applicable, in antibodies coating the patient's RBCs. For use in prenatal patients only to identify unexpected RBC antibodies and aid in determining the risk for hemolytic disease of the fetus and newborn (HDFN) and to evaluate the patient for Rh immunoglobulin administration. Do not use this test for nonprenatal patients. For nonprenatal patients, order RBC Antibody Identification Package IRL (3017610).
New York DOH Approval Status
Specimen Required
3 (7mL) lavender (K2EDTA) or pink (K2EDTA) AND 1 (7mL) plain red.
Do not freeze. Transport 3 (7 mL) whole blood EDTA AND 1 (7 mL) whole blood plain red. (Min: 10 mL EDTA and 3 mL plain red)
Refrigerated.
Separator tubes.
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable
Methodology
Qualitative Hemagglutination (HA)/Qualitative Solid Phase Red Cell Adherence
Performed
Mon-Fri
Reported
3-5 days
Reference Interval
Interpretive Data
Standard
Note
This test is for prenatal patients only. Includes: ABO/Rh type, direct Coombs, RBC antibody identification by one method.
Titers will be performed, at an additional charge, on prenatal specimens for clinically significant antibodies.
Red blood cell antigen testing will be added as indicated. Depending on antibody complexity, additional testing may be required. Additional charges apply.
Hotline History
Hotline History
CPT Codes
86900; 86901; 86880; 86870; additional CPT codes may apply
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0010248 | ABORh | 882-1 |
0013008 | Direct Coombs | 13946-9 |
0013500 | Antibody Identification |
Aliases
- 0013005
- IRL-ABID
- Newborn/Maternal Antibody Work-Up
- Prenatal Ab ID, RBC